Option chain shows key data for Pharming's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Pharming.

Pharming (NASDAQ:PHAR) Stock, Option Chain

PHARMING GROUP NV - ADR

Pharming

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Movers_Stocks

News

Intraday Update

Markets

Movers

Trading Ideas

ALGM

AVAH

BLDP

CMTG

DLTR

GIII

INTC

LEGH

MGTX

PHAR

QBTS

G-III Apparel Posts Better-Than-Expected Earnings, Joins Ballard Power Systems, Dollar General And Other Big Stocks Moving Higher On Thursday

Biotech

Health Care

General

Pharming&#39;s Phase 3 trial results for leniolisib in children with APDS demonstrate efficacy and safety, supporting future regulatory filings in 2025.

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

movers image

ACDC

ARRY

CMPS

CRMD

ENPH

GLPG

GTLS

GYRE

LUNR

PRTC

RCKT

XPEV

Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming Group

PHARMARON BEIJING U/ADR by PHARMARON BEIJING CO LTD.

PHARNEXT by Pharnext

PHarol SGPS SA

PharmChem Inc

PHARMA FOODS INTL CO by Pharma Foods International Co., Ltd.

Pharma Foods International Co Ltd

Pharma Mar SA

PHARM-BIO SERV INC by Pharma-Bio Serv, Inc.

Pharma-Bio Serv Inc

PharmaCielo Ltd

PHARMACOM BIOVET INC by PharmaCom BioVet, Inc.

PharmaCom BioVet Inc

PharmaCyte Biotech Inc

PHARMAROTH LABS INC by PharmaRoth Labs, Inc.

PharmaRoth Labs Inc

PHARMATHER HLDGS LTD by PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd

Pharmadrug Inc

Pharmagen Inc

PHARMAGREEN BIOTECH INC by Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc

Pharmala Biotech Holdings Inc

PHARMALA BIOTECH HLDG INC by PharmAla Biotech Holdings Inc.

PHARMARON BEIJING CO LTD by PHARMARON BEIJING CO LTD.

Pharmaron Beijing Co Ltd

PHARMING GROUP NV ORD by Pharming Group NV

Pharnext SA

Pharos Energy PLC

Pharvaris NV

Press Releases

Pharming Group to participate in November investor conference

Pharming announces positive topline data in pediatric clinical trial of leniolisib

Pharming announces public cash offer to the shareholders of Abliva AB

Management

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer

Pharming Group to participate in February investor conference

Pharming Group to report fourth quarter and full year 2024 financial results on March 13

Pharming Group to participate in March investor conference

Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders

Earnings

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

Akebia Therapeutics

AnaptysBio

ArriVent BioPharma

Bicara Therapeutics

Bicycle Therapeutics plc - American Depositary Shares

Bicycle Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

Cogent Biosciences

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Immunome

Immatics

KalVista Pharmaceuticals, Inc. - Common Stock

KalVista Pharma

Kura Oncology

LENZ Therapeutics

MeiraGTx Hldgs

Organogenesis Holdings

Precigen

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Relay Therapeutics

Sage Therapeutics

Sionna Therapeutics

Tyra Biosciences

Valneva

Verve Therapeutics

HC Wainwright & Co.

Oppenheimer

Jefferies

Comments

Pharming

Pharming (PHAR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga